OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A head‐to‐head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene–related peptide for chronic and episodic migraine
Francesco Saccà, Simone Braca, Mattia Sansone, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 63, Iss. 6, pp. 788-794
Open Access | Times Cited: 11
Francesco Saccà, Simone Braca, Mattia Sansone, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 63, Iss. 6, pp. 788-794
Open Access | Times Cited: 11
Showing 11 citing articles:
Medication “underuse” headache
Wanakorn Rattanawong, Alan M. Rapoport, Anan Srikiatkhachorn
Cephalalgia (2024) Vol. 44, Iss. 4
Open Access | Times Cited: 9
Wanakorn Rattanawong, Alan M. Rapoport, Anan Srikiatkhachorn
Cephalalgia (2024) Vol. 44, Iss. 4
Open Access | Times Cited: 9
Pharmacological differences and switching among anti‐CGRP monoclonal antibodies: A narrative review
Giorgio Dalla Volta, Antonio Munafò, Andrea Burgalassi, et al.
Headache The Journal of Head and Face Pain (2025)
Closed Access | Times Cited: 1
Giorgio Dalla Volta, Antonio Munafò, Andrea Burgalassi, et al.
Headache The Journal of Head and Face Pain (2025)
Closed Access | Times Cited: 1
Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review
Jean Schoenen, Annelies Van Dycke, Jan Versijpt, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 17
Jean Schoenen, Annelies Van Dycke, Jan Versijpt, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 17
Real-world experience with calcitonin gene-related peptide-targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers
Mamoru Shibata, Kazuki Fujita, Eri Hoshino, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Mamoru Shibata, Kazuki Fujita, Eri Hoshino, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Fremanezumab for the Treatment of Migraine Complicated by Medication Overuse: A Systematic Review
Ibrahim Hajjaj, Carlo Baraldi, Lanfranco Pellesi
Clinical Drug Investigation (2025)
Closed Access
Ibrahim Hajjaj, Carlo Baraldi, Lanfranco Pellesi
Clinical Drug Investigation (2025)
Closed Access
Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis
Jaime Fernández-Bravo-Rodrigo, Iván Cavero‐Redondo, Maribel Lucerón‐Lucas‐Torres, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176702-176702
Closed Access | Times Cited: 3
Jaime Fernández-Bravo-Rodrigo, Iván Cavero‐Redondo, Maribel Lucerón‐Lucas‐Torres, et al.
European Journal of Pharmacology (2024) Vol. 976, pp. 176702-176702
Closed Access | Times Cited: 3
Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study
Jason C. Ray, Linda J. Dalic, Josephine Baker, et al.
BMJ Neurology Open (2024) Vol. 6, Iss. 1, pp. e000547-e000547
Open Access | Times Cited: 2
Jason C. Ray, Linda J. Dalic, Josephine Baker, et al.
BMJ Neurology Open (2024) Vol. 6, Iss. 1, pp. e000547-e000547
Open Access | Times Cited: 2
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clinical and genetic study
Bruce A. Chase, Irene Semenov, Susan Rubin, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 64, Iss. 1, pp. 68-92
Open Access | Times Cited: 6
Bruce A. Chase, Irene Semenov, Susan Rubin, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 64, Iss. 1, pp. 68-92
Open Access | Times Cited: 6
Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study
Simone Braca, Angelo Miele, Antonio Stornaiuolo, et al.
Neurological Sciences (2023) Vol. 45, Iss. 4, pp. 1655-1660
Closed Access | Times Cited: 4
Simone Braca, Angelo Miele, Antonio Stornaiuolo, et al.
Neurological Sciences (2023) Vol. 45, Iss. 4, pp. 1655-1660
Closed Access | Times Cited: 4
Adding corticosteroids to galcanezumab in medication overuse headache: A three-arm head-to-head prospective observational cohort study
Simone Braca, Roberto De Simone, Antonio Stornaiuolo, et al.
Revue Neurologique (2024)
Open Access
Simone Braca, Roberto De Simone, Antonio Stornaiuolo, et al.
Revue Neurologique (2024)
Open Access
Comparative Study of the Efficacy of Anti-CGRP mAbs on Migraineurs: Analysis of the First Year of Therapy, 1-Month Suspension Period, and Reprisal
Yan Tereshko, Simone Dal Bello, Sara Pez, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7329-7329
Open Access
Yan Tereshko, Simone Dal Bello, Sara Pez, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7329-7329
Open Access
